KIT PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS FEBRILES.
Mexico·Clase I·III. Agentes de diagnóstico·LAB-CENTER DE
MÉXICO S.A. DE C.V.·Registered December 14, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- BACTERIAL ANTIGENS.
- Trade Name (English)
- BACTERIAL ANTIGENS.
- Analysis ID
- 1580R2022 SSA
- Registration Date
- December 14, 2022
- Name (Spanish)
- LAB-CENTER DE MÉXICO S.A. DE C.V.
- Name (English)
- LAB-CENTER DE MÉXICO S.A. DE C.V.
Access comprehensive regulatory information for KIT PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS FEBRILES. (KIT PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS FEBRILES.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1580R2022 SSA and manufactured by LAB-CENTER DE MÉXICO S.A. DE C.V.. The device was registered on December 14, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.